Continuous Glucose Monitoring for Type 2 Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical trial is to evaluate the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes (T2D):* The first aim is to determine how feasible it is to adapt the Continuous Glucose Monitoring Academy curriculum to teach youth with T2D glucose management strategies.* The second aim is to evaluate the effects of the Continuous Glucose Monitoring Academy metrics.* The third aim is to explore the relationships between these metrics with diabetes distress, diabetes family responsibilities, and process metrics.Participants will join for a total of four weeks of education, followed by a six-month clinical review. They will have access to an online workbook and videos, and will participate in virtual sessions with a diabetes educator who will cover glucose management strategies in-depth. Participants will wear their preferred Continuous Glucose Monitoring system (Dexcom or FreeStyle Libre) provided via insurance and inserted at the baseline visit.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is continuous glucose monitoring generally safe for humans?
How is Continuous Glucose Monitoring Academy different from other treatments for type 2 diabetes?
Continuous Glucose Monitoring Academy is unique because it uses a wearable device that continuously tracks glucose levels in the body, providing real-time data and alerts for high or low blood sugar, unlike traditional methods that require frequent finger-stick tests. This approach helps patients and doctors better understand and manage blood sugar patterns, potentially reducing complications like hypoglycemia (low blood sugar) and improving overall diabetes control.678910
What data supports the effectiveness of the treatment Continuous Glucose Monitoring Academy for Type 2 Diabetes?
Research shows that continuous glucose monitoring helps people with diabetes better understand their blood sugar patterns, which can lead to improved blood sugar control and lower hemoglobin A1c levels. This technology has been effective in both type 1 and type 2 diabetes, helping patients make informed decisions about their diet, insulin, and lifestyle.5781112
Who Is on the Research Team?
Rebecca Barber, PhD, RN
Principal Investigator
Children's Hospital Los Angeles
Are You a Good Fit for This Trial?
This trial is for young individuals aged 13-24 with Type 2 Diabetes who can speak, read, and write in English or Spanish. It's designed to help them manage their glucose levels better.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Education
Participants engage in a four-week education program with online workbooks, videos, and virtual sessions with a diabetes educator.
Clinical Review
Participants undergo a six-month clinical review to evaluate the impact of the education curriculum on glycemic outcomes.
Follow-up
Participants are monitored for safety and effectiveness after the education and clinical review phases.
What Are the Treatments Tested in This Trial?
Interventions
- Continuous Glucose Monitoring Academy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital Los Angeles
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator